3D mapping with sound waves for radiation therapy
Part of Cancer, Digestive system, Kidney & urinary clinical trials.
This study tests a new imaging device that uses sound waves to create a 3D map of the area being treated with radiation therapy. It aims to help doctors target the radiation more precisely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You are getting standard radiation therapy at the Stephenson Cancer Center.
- Your treatment is for a condition like liver or prostate cancer where this imaging can be used.
- You are willing and able to give written consent to participate.
- You do not have open wounds or skin conditions where the device would touch your skin.
- You do not have a pacemaker or other implanted electronic device in the area being treated.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special ultrasound imaging to look for early signs of how well radiation treatment is working in prostate, rectum, and head/neck cancers. It may help doctors spot response sooner and adjust care earlier if needed.
This trial studies whether a special ultrasound method (power Doppler ultrasound) can better guide where needles go during high-dose-rate radiation treatment for prostate cancer. The goal is to improve targeting during the procedure while you receive standard treatment.
This study tests how well an artificial intelligence system can use special X-ray images taken during certain radiation treatments to improve care. You may qualify if you’re having radiation for specific conditions and your treatment center uses the required imaging steps.
This trial studies whether a high-intensity focused ultrasound treatment can help people with localized prostate cancer while still avoiding traditional full-dose treatment for some patients. It may be an option for certain intermediate-risk cases where the cancer is confined to the prostate.
This trial tests a “master protocol” approach to use MRI (a detailed body scan) to help plan radiation treatment for people with cancer. It may help doctors customize radiation more accurately, depending on your specific cancer type.
This trial tests a newer, more precise type of radiation therapy for intermediate-risk prostate cancer using micro-ultrasound guidance to target the tumor. It aims to shorten treatment and reduce side effects while maintaining effectiveness.
Hear when a new Proton Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.